DocMorris AG (ZRSEF)
USD 39.03
(0.0%)
USD 39.03
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 51.75 Million CHF | -37.78% |
| 2022 | 83.18 Million CHF | -10.04% |
| 2021 | 92.46 Million CHF | -0.18% |
| 2020 | 92.63 Million CHF | 31.2% |
| 2019 | 70.6 Million CHF | 1.74% |
| 2018 | 69.4 Million CHF | 18.49% |
| 2017 | 58.57 Million CHF | 21.32% |
| 2016 | 48.27 Million CHF | 38.85% |
| 2015 | 34.76 Million CHF | -3.59% |
| 2014 | 36.06 Million CHF | 4.92% |
| 2013 | 34.37 Million CHF | -17.44% |
| 2012 | 41.63 Million CHF | 38.16% |
| 2011 | 30.13 Million CHF | 3.55% |
| 2010 | 29.09 Million CHF | -17.57% |
| 2009 | 35.3 Million CHF | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 44.27 Million CHF | -14.45% |
| 2024 Q2 | 44.27 Million CHF | 0.0% |
| 2023 Q2 | 43.65 Million CHF | 0.0% |
| 2023 FY | 51.75 Million CHF | -37.78% |
| 2023 Q4 | 51.75 Million CHF | 0.0% |
| 2023 Q3 | 51.75 Million CHF | 18.56% |
| 2023 Q1 | 43.65 Million CHF | -47.52% |
| 2022 Q4 | 83.18 Million CHF | 0.0% |
| 2022 FY | 83.18 Million CHF | -10.04% |
| 2022 Q2 | 70.41 Million CHF | 0.0% |
| 2022 Q3 | 83.18 Million CHF | 18.13% |
| 2022 Q1 | 70.41 Million CHF | -23.85% |
| 2021 Q1 | 83.93 Million CHF | -9.4% |
| 2021 FY | 92.46 Million CHF | -0.18% |
| 2021 Q4 | 92.46 Million CHF | 0.0% |
| 2021 Q3 | 92.46 Million CHF | 10.17% |
| 2021 Q2 | 83.93 Million CHF | 0.0% |
| 2020 FY | 92.63 Million CHF | 31.2% |
| 2020 Q1 | 105.71 Million CHF | 49.73% |
| 2020 Q4 | 92.63 Million CHF | -0.33% |
| 2020 Q2 | 105.71 Million CHF | 0.0% |
| 2020 Q3 | 92.94 Million CHF | -12.09% |
| 2019 Q3 | 70.6 Million CHF | 3.28% |
| 2019 Q4 | 70.6 Million CHF | 0.0% |
| 2019 FY | 70.6 Million CHF | 1.74% |
| 2019 Q1 | 68.36 Million CHF | -1.49% |
| 2019 Q2 | 68.36 Million CHF | 0.0% |
| 2018 Q1 | 60.71 Million CHF | 3.66% |
| 2018 FY | 69.4 Million CHF | 18.49% |
| 2018 Q4 | 69.4 Million CHF | 0.0% |
| 2018 Q3 | 69.4 Million CHF | 14.3% |
| 2018 Q2 | 60.71 Million CHF | 0.0% |
| 2017 Q1 | - CHF | -100.0% |
| 2017 FY | 58.57 Million CHF | 21.32% |
| 2017 Q4 | 58.57 Million CHF | -1.19% |
| 2017 Q3 | 59.27 Million CHF | 33.48% |
| 2017 Q2 | 44.41 Million CHF | 0.0% |
| 2016 Q1 | - CHF | -100.0% |
| 2016 FY | 48.27 Million CHF | 38.85% |
| 2016 Q4 | 48.27 Million CHF | 0.0% |
| 2016 Q3 | 48.27 Million CHF | 0.0% |
| 2016 Q2 | - CHF | 0.0% |
| 2015 Q3 | 34.76 Million CHF | 0.0% |
| 2015 Q2 | - CHF | 0.0% |
| 2015 FY | 34.76 Million CHF | -3.59% |
| 2015 Q4 | 34.76 Million CHF | 0.0% |
| 2015 Q1 | - CHF | -100.0% |
| 2014 FY | 36.06 Million CHF | 4.92% |
| 2014 Q4 | 36.06 Million CHF | 0.0% |
| 2014 Q3 | 36.06 Million CHF | 0.0% |
| 2014 Q2 | - CHF | 0.0% |
| 2014 Q1 | - CHF | -100.0% |
| 2013 Q2 | - CHF | 0.0% |
| 2013 Q3 | 34.37 Million CHF | 0.0% |
| 2013 Q4 | 34.37 Million CHF | 0.0% |
| 2013 FY | 34.37 Million CHF | -17.44% |
| 2013 Q1 | - CHF | 0.0% |
| 2012 FY | 41.63 Million CHF | 38.16% |
| 2011 FY | 30.13 Million CHF | 3.55% |
| 2010 FY | 29.09 Million CHF | -17.57% |
| 2009 FY | 35.3 Million CHF | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 129.52 Million USD | 60.039% |
| Café Serendipity Holdings, Inc. | - USD | -Infinity% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 0.64 USD | -8087187400.0% |
| HealthWarehouse.com, Inc. | 509.11 Thousand USD | -10066.249% |
| LIGAND PHARMACEUTICAL INC | 23.96 Million USD | -115.937% |
| MedGen, Inc. | - USD | -Infinity% |
| Omni Health, Inc. | 380.1 Thousand USD | -13516.62% |
| Oxford Investments Holdings Inc. | 124.35 Thousand USD | -41522.169% |
| Pineapple, Inc. | 4710.00 USD | -1098795.966% |
| ScripsAmerica, Inc. | 735.76 Thousand USD | -6934.602% |